Leading science, pioneering therapies


  1. Signalling molecule Wnt biases the earliest fate choices of pluripotent cells

    Mar 6

    During early development, cells in the embryo are able to form all specialised cell types, but because each cell happens to exist in a particular area of the embryo, these so-called pluripotent cells don't form all cell types, but only the ones typical of the position they find themselves in.

  2. CRM PhD student Yali Huang winner of video contest showcasing research on early embryo development

    Feb 4

    Abcam, a global leader in the supply of innovative protein research tools, announced CRM PhD student Yali Huang as the winner of its 15 discoveries contest. Yali is part of Prof Val Wilson’s Early Embryo Development lab. The video contest recognises the most innovative and exciting scientific breakthroughs of the last 18 months supported by Abcam products.

  3. Stem cell research may aid quest to repair damaged immunity

    Feb 3

    A major research initiative could pave the way for new stem cell therapies for people with damaged immune systems. The £5 million project may translate into new treatments that benefit older people and those who have received a bone marrow transplant.

  4. CRM Highlights 2013

    Jan 23

    If you would like to know more about the MRC Centre for Regenerative Medicine (CRM), please read our Highlights 2013 newsletter.

  5. Molecule E-cadherin plays key role in turning stem cells into nerve cells

    Dec 12

    CRM scientists are one step further in unravelling how embryonic stem (ES) cells become nerve cells.

  6. Mind Yer Brain: breaking down communication barriers

    Dec 11

    Neuroscience researchers from the University of Edinburgh have teamed up with a creative team led by Shift.ms to spark interest and address misconceptions in brain research.

  7. New report on stem cell research reveals the field is growing twice as fast as the world average.

    Dec 6

    A new report 'Stem Cell Research: Trends and Perspectives on the Evolving International Landscape' presents a comprehensive analysis of the growth and development of the stem cell field, with particular focus on embryonic stem (ES) cell and induced pluripotent stem (iPS) cell research outputs.

  8. Why stem cells need to stick with their friends

    Nov 7

    Scientists at the University of Edinburgh and University of Copenhagen have identified a core set of functionally relevant factors which regulates embryonic stem cells’ ability for self-renewal. A key aspect is the protein Oct4 and how it makes stem cells stick together. The identification of these factors will be an important tool in devising better and safer ways of making specialised cells for future regenerative cell therapies for treatment of diseases like diabetes and Parkinson’s disease.

  9. CRM student highlights 2013

    Oct 14

    The MRC Centre for Regenerative Medicine (CRM) currently has a vibrant PhD community of more than 60 students. As part of their training program, students are encouraged to get involved in activities that suit their personal interests and help build their CV.

  10. Anne Rowling Clinic opens with Royal seal of approval

    Oct 8

    Patients with multiple sclerosis and other neurological diseases are to benefit from a research clinic that was officially opened by Her Royal Highness, The Princess Royal today.

  11. £10M capital funding to build a new ‘stem cell niche’ facility

    Sep 10

    The Medical Research Council (MRC) and the University of Edinburgh announced yesterday that the MRC Centre for Regenerative Medicine (CRM) will receive £10M to build an extension to the Scottish Centre for Regenerative Medicine (SCRM) building.

  12. Licences granted for manufacture of human cell therapy products

    Aug 13

    Roslin Cells Ltd, the Scottish National Blood Transfusion Service (SNBTS) and the University of Edinburgh announced today that the GMP Cellular Therapy Manufacturing facility within the Scottish Centre for Regenerative Medicine (SCRM) has recently been licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) for the manufacture of human cell therapy products.

  13. CRM Scientists engage with Scottish communities at Music Festivals

    Jul 23

    CRM researchers have teamed up with researchers from other Universities in Scotland to showcase Scottish Stem Cell Science at T in the park and Tiree Music Festival.

  14. MS research points towards treatments to repair damaged nerves

    Jul 21

    Multiple sclerosis treatments that repair damage to the brain could be developed thanks to new research.

  15. Transatlantic partnership to tackle neurodegenerative disease

    Jul 18

    Research into multiple sclerosis and motor neurone disease is to be boosted with an international collaboration to further understanding of these illnesses.

  16. SCRM building wins New Laboratory Building of the Year award

    Jun 19

    The Scottish Centre for Regenerative Medicine (SCRM) building has been named as best new laboratory building in the S-Lab Awards, which recognise laboratories for sustainability, safety and success.

  17. Stem cells reach standard for use in drug development

    Jun 11

    Drug development for a range of conditions could be improved with stem cell technology that helps doctors predict the safety and the effectiveness of potential treatments.

  18. Stem cell study could aid quest to combat range of diseases

    Jun 2

    Scientists have taken a vital step forward in understanding how cells from skin tissue can be reprogrammed to become stem cells.

  19. CRM scientists connect with Scottish communities

    May 22

    The MRC Centre for Regenerative Medicine (CRM) has embarked on an ambitious public engagement project to travel to remote areas of Scotland with the aim to give local communities the opportunity to interact face-to-face with scientists working in the regenerative medicine field

  20. Stem cell discovery could aid research into new treatments

    May 2

    Scientists at the University of Edinburgh’s MRC Centre for Regenerative Medicine (CRM) have made a fundamental discovery about how the properties of embryonic stem cells are controlled. The study, which focuses on the process by which these cells renew and increase in number, could help research to find new treatments.